GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wowi WOWU · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in USD, from our data supplier.

FY2023

Revenue

$390,300

FY2015FY2023

Net income

$91,839

FY2015FY2023

Free cash flow

—

FY2015FY2023

Shareholders' equity

−$40,651

FY2015FY2023

Income statement

Fiscal years

FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Revenue$390,300$587,900$322,806$85,427———
Gross profit$358,340$555,940$322,805$85,426−$6,050——
Operating income$91,840$289,440−$24,080−$217,310−$30.6m−$803−$121
Net income$91,839$289,439−$24,082−$217,314−$34.4m−$1,682−$121
Diluted earnings per share0.000.01-0.00-0.01-1.14-0.00-0.00

Balance sheet

At each fiscal year end

FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Total assets$1.6m$1.8m$1.3m$1.0m$830,175$359$18
Cash and short-term investments————$178,411$227$18
Total liabilities$1.7m$1.7m$1.4m$1.1m$212,181$1,977$39
Debt$80,000$80,000$80,000$80,000$10,000$508—
Shareholders' equity−$40,651$156,939−$132,491−$108,473$617,994−$1,618−$20
Shares outstanding34m34m34m34m30m30m26m

Cash flow

Fiscal years

FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Cash from operations——−$65—−$652,055−$211$110
Capital spending————−$355,263−$34−$34,400
Free cash flow——−$65—−$1.0m−$246−$34,290

Latest quarters

By quarter end

Sept 2021Jun 2021Mar 2021Jun 2017Mar 2017Dec 2016Jun 2016Mar 2016
Revenue$53,033$123,600$95,317—————
Gross profit$53,033$123,600$95,317—————
Operating income−$20,180−$105,220−$3,340−$133−$146−$12,547−$37−$36
Net income−$20,184−$106,119−$3,337−$217−$747−$12,944$99−$125
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.000.00-0.00
Total assets$1.3m$1.4m$1.1m$853$922———
Cash and short-term investments———$266$563$227——
Debt$80,000$80,000$80,000$1.3m$1.3m———
Shareholders' equity−$132,491$336,729−$147,510−$2,877−$2,659−$1,618——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue65.9%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin93.5%95.4%——
Operating margin39.0%10.1%——
Net margin39.0%10.1%——

Valuation history

At each fiscal year end

FY2023FY2022FY2021FY2020FY2015
Price to earnings2.02.8-1.7-0.0-0.0
Price to sales0.51.40.10.1—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-99%144%-77%1822%756%9389%-24%206%489%113%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 300-to-1 reverse split · 19 Nov 2009
  • 5-for-1 split · 26 Sept 2005
  • 5-to-1 reverse split · 9 Feb 2004
  • 50-to-1 reverse split · 14 Oct 2003
  • 10-to-1 reverse split · 1 Feb 2002
  • 10-to-1 reverse split · 24 Sept 1997

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.